What is Tianjin Tianyao Pharmaceuticals Co., Ltd.'s (600488.SS) StockRank?

MoatMap's StockRank for Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS) is 40/100, with a Hold signal. This is a composite score combining Quality (53), Value (29), and Momentum (50) factor ranks across MoatMap's 19,000+ stock universe.

Does Tianjin Tianyao Pharmaceuticals Co., Ltd. have an economic moat?

Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS) has a Quality factor score of 53/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Tianjin Tianyao Pharmaceuticals Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS) is Hold, based on a StockRank of 40/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Tianjin Tianyao Pharmaceuticals Co., Ltd. in?

Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

600488.SS

HOLDREMOVE

Tianjin Tianyao Pharmaceuticals Co., Ltd. · Healthcare · China · $894M · Avg Vol: $80M/d

StockRank

P/E (TTM)

162.3x

ROE

1.6%

D/E

0.2x

Dividend %

1.1%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

A manufacturer of corticosteroid APIs and formulations. While it operates in healthcare, it lacks the high-margin, proprietary platform characteristics of a quality CDMO, operating instead in a highly competitive, low-margin generic market.

COMPANY DESCRIPTION

Tianjin Tianyao Pharmaceuticals is a leading global manufacturer of corticosteroid active pharmaceutical ingredients (APIs) and finished dosages. The company is one of the largest steroid hormone production bases in Asia, with products exported to Europe, the Americas, and Southeast Asia. Its competitive advantage lies in its international regulatory certifications (such as FDA and CEP) and its highly optimized, large-scale chemical synthesis processes.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	545M	559M	475M	430M	-7.6%
EPS	0.00	0.02	0.02	0.01	26.6%
Shares	1.1B	1.1B	1.1B	1.1B	-0.4%
Debt	428M	353M	268M	109M	-36.7%
Equity	439M	437M	452M	448M	0.7%
Op CF	97M	116M	84M	20M	-40.7%
Inv CF	-29M	-20M	-11M	8M	—
Fin CF	-8M	-83M	-91M	2M	—

PRICE (1M)-19.3%

SMA 50SMA 200

$0.70

RSI (14)

43.3

52W High

$1.25

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

3.1%51.0

ROE

1.6%47.8

GP/Assets

18.1%42.3

Op. Margin

8.7%63.3

FCF/Assets

0.3%52.1

Piotroski

—83.5

Int. Cover

7.0x59.2

D/E Ratio

0.18x55.2

Current Ratio

2.08x38.1

Value

P/E (TTM)

162.3x5.8

EV/EBITDA

13.5x31.4

P/FCF

2215.2x3.9

P/B

1.7x60.3

P/S

1.9x68.8

Div Yield

1.1%29.8

Momentum

52W High %

56%33.8

RS 6M

1%77.5

SMA 50/200

1.28x93.4

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

-76%4.2

FUNDAMENTALS

Market Cap

$894M

P/E (Forward)

—

Gross Margin

38.0%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 600488.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
600488.SS	Tianjin Tianyao Pharmaceuticals Co., Ltd.(you)	$894M	40	HOLD
000813.SZ	Dezhan Healthcare Company Limited	$1.0B	42	HOLD
002688.SZ	Jinhe Biotechnology CO., LTD.	$628M	39	HOLD
300194.SZ	Fuan Pharmaceutical (Group) Co., Ltd.	$672M	43	HOLD
600829.SS	HPGC Renmintongtai Pharmaceutical Corporation	$746M	46	HOLD
300158.SZ	Shanxi Zhendong Pharmaceutical Co.,Ltd	$738M	34	SELL
688117.SS	ChengDu ShengNuo Biotec Co.,Ltd.	$785M	48	HOLD
300267.SZ	Hunan Er-Kang Pharmaceutical Co., Ltd	$1.1B	34	SELL
688176.SS	Jiangsu Yahong Meditech Co., Ltd.	$961M	30	SELL
002038.SZ	Beijing SL Pharmaceutical Co., Ltd.	$893M	28	SELL

Peer medians: ROE 4.8% · P/E 27.6x · Gross margin 53.1%

Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS) — Stock Score Summary

Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS) has a MoatMap StockRank of 40/100 based on Quality (53/100), Value (29/100), and Momentum (50/100) factor scores. The current signal is HOLD. A manufacturer of corticosteroid APIs and formulations. While it operates in healthcare, it lacks the high-margin, proprietary platform characteristics of a quality CDMO, operating instead in a highly competitive, low-margin generic market.

Key Financial Metrics

Price	$0.70
Market Cap	$894M
P/E (TTM)	162.33
Price/Book	1.74
Return on Equity	1.6%
Return on Invested Capital	3.1%
Debt/Equity	17.53
Gross Margin	38.0%
Operating Margin	8.7%
Revenue Growth	-22.6%
Dividend Yield	1.1%
Free Cash Flow	$404K

Tianjin Tianyao Pharmaceuticals Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Tianjin Tianyao Pharmaceuticals Co., Ltd.’s (600488.SS) StockRank?: MoatMap’s StockRank for Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS) is 40/100, with a Hold signal. It is a composite of Quality (53), Value (29), and Momentum (50) factor ranks across MoatMap’s 19,000+ stock universe.
Does Tianjin Tianyao Pharmaceuticals Co., Ltd. have an economic moat?: Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS) has a Quality factor score of 53/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Tianjin Tianyao Pharmaceuticals Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS) is Hold, based on a StockRank of 40/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Tianjin Tianyao Pharmaceuticals Co., Ltd. in?: Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).